See tip sheet for more information (internal link).
Solid tumors (e.g. sarcomas, lung cancers, thyroid cancers, head and neck cancers, renal cell carcinomas, mammary gland tumors, prostate cancers, brain tumors) frequently have chromosome rearrangements and gene fusions that are important in establishing a diagnosis, predicting prognosis, and guiding therapy choices. The FusionPlex® Solid Tumor Panel is based on next generation sequencing of RNA (cDNA) from solid tumor tissue to detect somatic oncogenic gene fusions involving any of 100 genes associated with solid tumors, without prior knowledge of the fusion partners or the breakpoints of the translocations. This test can also be ordered for a single gene or a subset of 2-10 genes, chosen by the ordering clinician based on clinical and pathological findings. Testing is performed by UWMC - Montlake DLMP Clinical Genomics Laboratory.
Epic Ordering:
Outside Providers: CGL Neoplasia Test Request Form
Providers with access to the UW implementation of Epic (i.e., FHCC, HMC, UWMC, UWNW) may order this test using the order "UW Genetics and Solid Tumor Test Request." See tip sheet for more information (internal link).
Total nucleic acid (TNA) is extracted from the sample using standard procedures. First- and second-strand complementary DNA (cDNA) synthesis is performed. A library of DNA fragments is constructed for targeted capture of cDNA from fusion genes using a custom designed FusionPlex® BBI Solid Tumor panel and reagent kit (ArcherDX, Boulder, CO). The library is quantitated using quantitative PCR and normalized for next generation sequencing. Paired-end sequencing of the enriched library is performed using Mid Output v2 (Illumina) chemistry on a NextSeq sequencer according to the manufacturer’s recommended protocol (Illumina, Inc. San Diego, CA). FASTQ files with base call and quality information of minimum 4.5 million paired-end sequence reads are processed using Archer Analysis software to annotate gene fusions and variants found within these genes. Human Genome build GRCh37 (hg19) is used. Additional details about this assay are available.
The FusionPlex® Solid Tumor Panel test does not detect gene fusions located outside the targeted gene regions. This test is also has limited ability to detect low-level mosaicism (<10%).
FFPE Tumor Slides:
FFPE Tumor Block:
Fresh Frozen Tumor Tissue:
Extracted RNA:
Outside Providers: CGL Neoplasia Test Request Form
Providers with access to the UW implementation of Epic (i.e., FHCC, HMC, UWMC, UWNW) may order this test using the order "UW Genetics and Solid Tumor Test Request." See tip sheet for more information (internal link).
Outside Laboratories:
Hold samples at room temperature. If sample was frozen when received, keep frozen until pick up.
Pathology |
Clinical Genomics Laboratory
206-598-8684 |
---|
Clinical Genomics Laboratory
University of Washington Health Sciences Building
Room H-561
1959 NE Pacific St
Seattle, WA 98195
Ph: (206) 616-4062
CPT code: 81455
Prior Insurance Authorization: Contact gpab@uw.edu for details